Bharat Biotech, in a statement on Thursday, said that its Covid-19 vaccine Covaxin has an excellent safety record without any vaccine-associated incidents of
blood clots, thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc, as it was developed with a singleminded focus on safety first, followed by efficacy.
No Comments For This Post, Be first to write a Comment.